PNC Financial Services Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.16K | Buy |
548
+538
| +5,380% | +$4.82K | ﹤0.01% | 4374 |
|
|
2026
Q1 | $81 | Hold |
10
| – | – | ﹤0.01% | 5106 |
|
|
2025
Q4 | $67 | Sell |
10
-535
| -98% | -$4.03K | ﹤0.01% | 5087 |
|
|
2025
Q3 | $4.73K | Buy |
545
+153
| +39% | +$1.19K | ﹤0.01% | 4228 |
|
|
2025
Q2 | $2.47K | Sell |
392
-1,365
| -78% | -$9.04K | ﹤0.01% | 4356 |
|
|
2025
Q1 | $11.3K | Buy |
1,757
+16
| +0.9% | +$132 | ﹤0.01% | 3785 |
|
|
2024
Q4 | $14K | Sell |
1,741
-1,670
| -49% | -$16.1K | ﹤0.01% | 3682 |
|
|
2024
Q3 | $43.1K | Sell |
3,411
-415
| -11% | -$5.36K | ﹤0.01% | 3165 |
|
|
2024
Q2 | $48.4K | Sell |
3,826
-511
| -12% | -$5.14K | ﹤0.01% | 3052 |
|
|
2024
Q1 | $20.7K | Buy |
4,337
+949
| +28% | +$4.4K | ﹤0.01% | 3434 |
|
|
2023
Q4 | $16.3K | Buy |
3,388
+984
| +41% | +$6.02K | ﹤0.01% | 3547 |
|
|
2023
Q3 | $17.4K | Buy |
2,404
+1,210
| +101% | +$9.67K | ﹤0.01% | 3496 |
|
|
2023
Q2 | $8.87K | Buy |
1,194
+691
| +137% | +$5.43K | ﹤0.01% | 3926 |
|
|
2023
Q1 | $3.49K | Buy |
503
+84
| +20% | +$773 | ﹤0.01% | 4157 |
|
|
2022
Q4 | $4.31K | Sell |
419
-266
| -39% | -$4.69K | ﹤0.01% | 4040 |
|
|
2022
Q3 | $12K | Sell |
685
-80
| -10% | -$3.47K | ﹤0.01% | 3673 |
|
|
2022
Q2 | $40K | Sell |
765
-159
| -17% | -$8.24K | ﹤0.01% | 3135 |
|
|
2022
Q1 | $68K | Sell |
924
-214
| -19% | -$19.1K | ﹤0.01% | 2939 |
|
|
2021
Q4 | $164K | Sell |
1,138
-520
| -31% | -$89.3K | ﹤0.01% | 2381 |
|
|
2021
Q3 | $344K | Sell |
1,658
-78
| -4% | -$17.2K | ﹤0.01% | 1860 |
|
|
2021
Q2 | $368K | Buy |
1,736
+518
| +43% | +$94.9K | ﹤0.01% | 1817 |
|
|
2021
Q1 | $220K | Buy |
1,218
+306
| +34% | +$61K | ﹤0.01% | 2117 |
|
|
2020
Q4 | $101K | Buy |
912
+120
| +15% | +$12.8K | ﹤0.01% | 2480 |
|
|
2020
Q3 | $86K | Buy |
792
+67
| +9% | +$8.16K | ﹤0.01% | 2413 |
|
|
2020
Q2 | $61K | Buy |
725
+500
| +222% | +$19.1K | ﹤0.01% | 2650 |
|
|
2020
Q1 | $3K | Buy |
225
+215
| +2,150% | +$1.82K | ﹤0.01% | 3682 |
|
|
2019
Q4 | $0 | Buy |
+10
| New | +$43 | ﹤0.01% | 4067 |
|
|
2017
Q1 | – | Sell |
-360
| Closed | -$10K | – | 4173 |
|
|
2016
Q4 | $10K | Sell |
360
-213
| -37% | -$6.21K | ﹤0.01% | 3487 |
|
|
2016
Q3 | $23K | Buy |
573
+1
| +0.2% | +$129 | ﹤0.01% | 3156 |
|
|
2016
Q2 | $83K | Sell |
572
-1,760
| -75% | -$202K | ﹤0.01% | 2578 |
|
|
2016
Q1 | $241K | Sell |
2,332
-8,287
| -78% | -$889K | ﹤0.01% | 1979 |
|
|
2015
Q4 | $1.78M | Sell |
10,619
-100
| -0.9% | -$15.4K | ﹤0.01% | 956 |
|
|
2015
Q3 | $1.52M | Buy |
10,719
+102
| +1% | +$22.9K | ﹤0.01% | 1064 |
|
|
2015
Q2 | $2.37M | Buy |
10,617
+33
| +0.3% | +$5.8K | ﹤0.01% | 912 |
|
|
2015
Q1 | $1.75M | Buy |
10,584
+559
| +6% | +$90.8K | ﹤0.01% | 1016 |
|
|
2014
Q4 | $1.19M | Hold |
10,025
| – | – | ﹤0.01% | 1125 |
|
|
2014
Q3 | $836K | Hold |
10,025
| – | – | ﹤0.01% | 1190 |
|
|
2014
Q2 | $926K | Buy |
10,025
+1,325
| +15% | +$116K | ﹤0.01% | 1123 |
|
|
2014
Q1 | $788K | Sell |
8,700
-10
| -0.1% | -$1.12K | ﹤0.01% | 1166 |
|
|
2013
Q4 | $892K | Buy |
8,710
+10
| +0.1% | +$707 | ﹤0.01% | 1081 |
|
|
2013
Q3 | $548K | Buy |
+8,700
| New | +$490K | ﹤0.01% | 1293 |
|
Other funds holding NVAX
S
TCMG
MAM
OC
PNC Financial Services Group's NVAX Position: Q2 2026 in Review
PNC Financial Services Group increased its Novavax (NVAX) stake by 5,380% in Q2 2026, buying an estimated $4.82K and bringing the position to 548 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4374.
PNC Financial Services Group first reported a position in NVAX in Q3 2013 and has held it in 41 quarters since. The position peaked at $2.37M in Q2 2015. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- PNC Financial Services Group held 548 shares of Novavax worth $5.16K as of Q2 2026.
- PNC Financial Services Group bought 538 Novavax shares in Q2 2026, an estimated $4.82K.
- Novavax made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4374 holding.
- PNC Financial Services Group first reported a position in Novavax in Q3 2013 and has held it in 41 quarters since.
- PNC Financial Services Group's Novavax position peaked at $2.37M in Q2 2015.
- 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.